| |
| |
|
| Insider
Information: |
Cathers Brian Edwin |
| Relationship: |
Chief Scientific Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
12,005 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$822,222 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
12,005 |
|
|
| Total
Value |
$822,222 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Global Blood Therapeutics, Inc. |
GBT |
Chief Scientific Officer |
2021-03-01 |
12,005 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GBT |
Global Blood Therapeutics... |
Chief Scientific Officer |
• – – |
2021-03-01 |
4 |
D |
$44.48 |
$57,691 |
D/D |
(1,297) |
12,005 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Scientific Officer |
• – – |
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
13,302 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Scientific Officer |
• – – |
2021-02-01 |
4 |
D |
$49.49 |
$58,299 |
D/D |
(1,178) |
9,552 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Scientific Officer |
• – – |
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,020 |
10,730 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Scientific Officer |
• – – |
2021-02-01 |
4 |
A |
$41.17 |
$10,992 |
D/D |
267 |
7,710 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Scientific Officer |
• – – |
2020-09-01 |
4 |
D |
$60.45 |
$93,758 |
D/D |
(1,551) |
7,443 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Scientific Officer |
• – – |
2020-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
8,994 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Scientific Officer |
• – – |
2020-08-20 |
4 |
S |
$63.77 |
$140,294 |
D/D |
(2,200) |
5,244 |
0 |
% |
|
| GBT |
Global Blood Therapeutics... |
Chief Scientific Officer |
• – – |
2020-08-01 |
4 |
D |
$67.48 |
$70,517 |
D/D |
(1,045) |
7,444 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Scientific Officer |
• – – |
2020-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,020 |
8,489 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Scientific Officer |
• – – |
2020-07-31 |
4 |
A |
$41.17 |
$11,939 |
D/D |
290 |
5,469 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Scientific Officer |
• – – |
2020-03-01 |
4 |
D |
$63.96 |
$165,912 |
D/D |
(2,594) |
5,179 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Scientific Officer |
• – – |
2020-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
7,773 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Scientific Officer |
• – – |
2020-01-31 |
4 |
A |
$41.17 |
$11,239 |
D/D |
273 |
273 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
